Temporal association of sNfL and gad‐enhancing lesions in multiple sclerosis
Abstract
Multiple sclerosis (MS) is an autoimmune demyelinating disorder, which is characterized by relapses and remissions. Serum neurofilament light chain (sNfL) is an emerging biomarker of disease activity but its clinical use is still limited. In this study, we aim to characterize the temporal association between sNfL and new clinical relapses and new gadolinium‐enhancing (Gd+) lesions.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 25, 2020
- Source ID
- 10.1002/acn3.51060
Entities
People
- Anu Paul
- Brian C. Healy
- Charles R Guttmann
- Cindy T. Gonzalez
- David Leppert
- Howard L. Weiner
- Jens Kuhle
- Kjetil Bjornevik
- Mattia Rosso
- Pascal Benkert
- Rohit Bakshi
- Shrishti Saxena
- Tanuja Chitnis
Organizations
- EMD Serono (United States)
- Harvard Medical School
- Harvard University
- Massachusetts General Hospital
- Race to Erase MS
- United States Department of Defense
- University of Basel